![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ob6066contents.gif)
Acta Cryst. (2001). E57, o906-o908 [ doi:10.1107/S1600536801014222 ]
Abstract: The title compound, C19H23N2O5P, is one of two diastereomers of an arylphosphonamide hydroxamate. The absolute configuration has been determined to establish the relationship between the stereochemistry at the P atom and the activity in inhibition of matrix metalloproteinases.
Online 11 September 2001
Copyright © International Union of Crystallography
IUCr Webmaster